Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.

MLA

Appenrodt, Beate, et al. “Prevention of Paracentesis-Induced Circulatory Dysfunction: Midodrine vs Albumin. A Randomized Pilot Study.” Liver International : Official Journal of the International Association for the Study of the Liver, vol. 28, no. 7, Aug. 2008, pp. 1019–25. EBSCOhost, https://doi.org/10.1111/j.1478-3231.2008.01734.x.

APA

Appenrodt, B., Wolf, A., Grünhage, F., Trebicka, J., Schepke, M., Rabe, C., Lammert, F., Sauerbruch, T., & Heller, J. (2008). Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver International : Official Journal of the International Association for the Study of the Liver, 28(7), 1019–1025. https://doi.org/10.1111/j.1478-3231.2008.01734.x

Chicago

Appenrodt, Beate, Andrea Wolf, Frank Grünhage, Jonel Trebicka, Michael Schepke, Christian Rabe, Frank Lammert, Tilman Sauerbruch, and J Heller. 2008. “Prevention of Paracentesis-Induced Circulatory Dysfunction: Midodrine vs Albumin. A Randomized Pilot Study.” Liver International : Official Journal of the International Association for the Study of the Liver 28 (7): 1019–25. doi:10.1111/j.1478-3231.2008.01734.x.